Showing results (11-20 of 482) with videos related to
Sort By:
Pageof 49
Digestive Diseases (Basel, Switzerland)|June 26, 2013
Primary sclerosing cholangitis and cholangiocarcinoma: pathogenesis and modes of diagnosticsHanno Ehlken, Christoph SchrammClinics and Research in Hepatology and Gastroenterology|September 9, 2017
Autoimmune hepatitis - update on clinical management in 2017Timur Liwinski, Christoph SchrammInnere Medizin (Heidelberg, Germany)|March 7, 2024
[Primary biliary cholangitis-response criteria of first-line treatment and perspectives of second-line therapy]Silja Steinmann, Christoph SchrammJournal of Immunology (Baltimore, Md. : 1950)|November 24, 2004
Cutting edge: TGF-beta signaling is required for the in vivo expansion and immunosuppressive capacity of regulatory CD4+CD25+ T cellsSamuel Huber, Christoph Schramm, Hans A Lehr, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 4, 2009
Activin a promotes the TGF-beta-induced conversion of CD4+CD25- T cells into Foxp3+ induced regulatory T cellsSamuel Huber, Felix R Stahl, Jörg Schrader, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 20, 2008
Coexpression of TGF-beta1 and IL-10 enables regulatory T cells to completely suppress airway hyperreactivityKatrin Presser, Dorothee Schwinge, Michael Wegmann, et al.Journal of Hepatology|September 20, 2012
Inhibition of inflammatory CD4 T cell activity by murine liver sinusoidal endothelial cellsAntonella Carambia, Christian Frenzel, Oliver T Bruns, et al.Zeitschrift Fur Gastroenterologie|January 26, 2026
[Immunopathogenesis and therapy of primary sclerosing cholangitis]Britta F Zecher, Christoph SchrammClinical Reviews in Allergy & Immunology|May 10, 2005
Overlap syndromes of cholestatic liver diseases and auto-immune hepatitisChristoph Schramm, Ansgar W LohseCellular and Molecular Gastroenterology and Hepatology|September 21, 2023
IFNγ and CTLA-4 Drive Hepatic CD4 T-Cell Tolerance and Protection From Autoimmunity in MiceDaria Krzikalla, Alena Laschtowitz, Lisa Leypoldt, et al.Pageof 49